# Junta clínica — PT-pseudo_a2ed5cd06259 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_a2ed5cd06259",
  "pid": "PT-pseudo_a2ed5cd06259",
  "task": 1,
  "psa": 4.6,
  "age": 76,
  "months": 3,
  "pirads": "5",
  "psad": 0.153,
  "psav": 0.81,
  "psap": 3.4,
  "vol": 30.02,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.8208632,
  "medhx": "Type 2 diabetes",
  "meds": "empagliflozin",
  "notes": "PSA 4.6 ng/mL. PI-RADS 5. PSAD 0.15. Prostate volume 30 mL. csPCa 0.82.",
  "pmhx": [
    "Type 2 diabetes"
  ],
  "allergies": [],
  "vitals": {
    "weight": "103 kg",
    "height": "193 cm",
    "bmi": "27.7",
    "bp": "137/83 mmHg",
    "hr": "65 bpm",
    "smoking": "Non-smoker",
    "last_dental": "3 yr ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "10 Jan 2025",
  "enc_ref": "Dr. T. Hendriks (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Ascending PSA values combined with a previously positive biopsy require specialist re-evaluation."
    },
    {
      "s": "History",
      "t": "A 76-year-old non-smoker initially entered evaluation due to a late-2023 PSA elevation. Later, a systematic biopsy confirmed low-grade disease. Type 2 diabetes is managed using empagliflozin. An IPSS score of 2 points to negligible urinary symptom bother. Formerly a police officer, he is divorced and resides with his partner. Weekends feature hiking trips. Alcohol remains capped at 13 units weekly. Orthopaedic follow-ups address a chronic knee issue. Podiatry visits handle foot maintenance. An Arabic interpreter has been requested. Bone pain, haematuria, and unexplained weight loss are denied. Overall wellness stays steady."
    },
    {
      "s": "Physical examination",
      "t": "DRE: Texture is uniformly smooth. Dimensions are symmetric. No nodularity. No asymmetry. General inspection shows a well-nourished individual appearing comfortable. Vital signs remain stable. Cardiopulmonary assessment is normal."
    }
  ],
  "occupation": "retired police officer",
  "marital": "Divorced",
  "living": "Lives with partner",
  "next_of_kin": "Spouse / partner (primary contact)",
  "recent_other": [
    "Orthopaedic outpatient — knee follow-up",
    "Podiatry — routine foot care"
  ],
  "alcohol": "13 units / week",
  "exercise": "Hiking on weekends",
  "ipss": "IPSS score: 2/35 (mild LUTS)",
  "admin": "Interpreter (Arabic) requested for next visit.",
  "mri_hospital": "Amsterdam UMC (location AMC)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_a2ed5cd06259
Task: 1

Encounter: Urology - outpatient on 10 Jan 2025.
Referrer: Dr. T. Hendriks (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 76-year-old male
  - PSA: 4.6 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.153 ng/mL²
  - PSA velocity: 0.81 ng/mL/yr
  - Prior PSA: 3.4 ng/mL
  - Prostate volume: 30.02 mL
  - Months since last PSA: 3
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.8208632 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Type 2 diabetes
  - Problem list / PMHx: Type 2 diabetes
  - Current medication: empagliflozin
  - Allergies: NKA
  - Additional notes: PSA 4.6 ng/mL. PI-RADS 5. PSAD 0.15. Prostate volume 30 mL. csPCa 0.82.

Vitals: weight 103 kg, height 193 cm, BMI 27.7, BP 137/83 mmHg, HR 65 bpm. Smoking: Non-smoker.

Chief complaint: Ascending PSA values combined with a previously positive biopsy require specialist re-evaluation.

History: A 76-year-old non-smoker initially entered evaluation due to a late-2023 PSA elevation. Later, a systematic biopsy confirmed low-grade disease. Type 2 diabetes is managed using empagliflozin. An IPSS score of 2 points to negligible urinary symptom bother. Formerly a police officer, he is divorced and resides with his partner. Weekends feature hiking trips. Alcohol remains capped at 13 units weekly. Orthopaedic follow-ups address a chronic knee issue. Podiatry visits handle foot maintenance. An Arabic interpreter has been requested. Bone pain, haematuria, and unexplained weight loss are denied. Overall wellness stays steady.

Physical examination: DRE: Texture is uniformly smooth. Dimensions are symmetric. No nodularity. No asymmetry. General inspection shows a well-nourished individual appearing comfortable. Vital signs remain stable. Cardiopulmonary assessment is normal.

Patient info: retired police officer; Divorced; Lives with partner.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 13 units / week; exercise Hiking on weekends; IPSS score: 2/35 (mild LUTS).

Recent other appointments: Orthopaedic outpatient — knee follow-up; Podiatry — routine foot care.
Admin: Interpreter (Arabic) requested for next visit.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.57
  uncertainty  +/- 0.10 epistemic (95% band 0.37-0.76); among patients I cannot tell apart the outcome was 0.99 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 1 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 76 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 4.6 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 30.02 mL (1% of my signal; from log_vol, vol) · PSA density = 0.153 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.82 (1% of my signal; from cspca) · PI-RADS = 5 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 76 · DRE = Normal · PSA = 4.6 ng/mL · prostate volume = 30.02 mL · PSA density = 0.153 · PI-RADS = 5 · comorbidity = 1 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-EXPERIENCE

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

I recall 49 men I have seen in this same situation (Positive prior biopsy). The 3 most similar patients, and what the reading urologist did:
  1. distance 0.94: PI-RADS 5, PSA 5.5, PSAD 0.12, age 71, DRE Normal -> BIOPSY (clear). He wrote: "Prev biopsy finding is left lobe, MRI finding highly suspicious of ISUP≥2 on right side. Active surveillance, only 1 biopsy session performed (of unclear date and unclea…"
  2. distance 1.15: PI-RADS 5, PSA 10.0, PSAD 0.27, age 75, DRE Normal -> BIOPSY (clear). He wrote: "New(? -> no old MRI report included) PIRADS 5 and rising PSA makes biopsy necessary"
  3. distance 1.31: PI-RADS 5, PSA 10.0, PSAD 0.372, age 75, DRE Normal -> BIOPSY (clear). He wrote: "Intermediate risk disease in 75yr with some comorbidity. No targeted biopsy and unclear timing (when was diagnosis and prev biopsy). Unclear if PIRADS5 was biopsied (lim…"

PRECEDENT: BIOPSY (weighted vote 1.00 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What my professional experience contributes: it shows what this urologist looks at and how he phrases the call. These memories do not establish facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  decisive   PI-RADS = 5
  important  prior biopsy = Positive · age = 76 · PSA = 4.6 ng/mL · csPCa probability = 0.82
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 30.02 mL · PSA density = 0.153 · comorbidity = 1 on the problem list
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  important  prior biopsy = Positive · age = 76 · PSA = 4.6 ng/mL · PI-RADS = 5
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 30.02 mL · PSA density = 0.153 · comorbidity = 1 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines suggest that the decision to perform a biopsy should be guided by a risk-adapted approach, considering factors such as the PI-RADS score and PSA density. The guideline states, "This risk-adapted matrix table may guide the decision to perform a biopsy."

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, I note that the guideline makes the variable 'prior biopsy = Positive' context, whereas the guideline suggests the decision should be guided by the risk-adapted matrix table. The guideline requires the PI-RADS score and PSA density to guide the decision, which the expert marked as 'noted' but not 'decisive'. The guideline suggests that for a patient with a PI-RADS 5 and PSA density of 0.153, the decision should be guided by the risk-adapted matrix table. The guideline requires the prior grade of the prior biopsy to be known to determine the next step, which the expert marked as 'decisive'. The guideline suggests that the decision should be guided by the PI-RADS score and PSA density, which the expert marked as 'noted'. The guideline requires the patient to have a documented prior grade of the prior biopsy to determine the next step, which the expert marked as 'decisive'. The guideline requires the patient to have a documented prior grade of the prior biopsy to determine the next step, which the expert marked as 'decisive'.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - whether the PSA trend is significant: a rising PSA trend is a factor in risk stratification
laboratory_results - whether the PSA density is below 0.15ng/mL/cc: this is a factor in risk stratification

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

The case hinges entirely on the documented grade of the prior biopsy, as the cohort expert noted that the panel alone is insufficient.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the lesion size and zone information support re-sampling?
  psa_trend (get_psa_trend) -> Is the PSA trend significant?
  previous_notes (get_previous_notes) -> What is the grade of the prior biopsy (Gleason or ISUP), and is there a surveillance protocol?
  laboratory_results (get_lab_results) -> Is the PSA density below 0.15ng/mL/cc?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade of the prior biopsy?
  Q2. Is the PSA trend significant?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report: Subject: Multiparametric MRI Prostate. The lesion size and zone information is a focal hypointense area within the right anterior mid-gland zone, spanning roughly 12 x 10 mm. This finding suggests re-sampling might be relevant.
psa_trend: The PSA trend is significant, showing a rise from 0.7 ng/mL in Dec 2023 to 4.6 ng/mL in Jan 2025.
previous_notes: The grade of the prior biopsy is not explicitly stated as Gleason or ISUP, but notes mention "previous biopsy results" followed by a referral. There is no explicit mention of a surveillance protocol.
laboratory_results: The PSA density is 0.153 ng/mL/mL, which is not below the 0.15 ng/mL/cc threshold.

WHAT I DID NOT OPEN
family-history anamnesis, because the cohort expert noted it was not weighed by the reading urologist.

WHAT THIS SUPPORTS
FOR sampling this patient now:
The PI-RADS 5 finding from the MRI is highly concerning.
The PSA trend is significant, indicating disease progression.
AGAINST sampling this patient now:
The PSA density is not below the threshold for risk stratification according to the EAU guideline context.

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 4.60 ng/mL over 5 points spanning 13 months; velocity +3.13 ng/mL per year; doubling time about 5 months.
PROJECTION at 6 months: 7.0 ng/mL, conformal 95% band 2.0-24.2.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 4.6 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.53
  uncertainty  +/- 0.10 epistemic (95% band 0.34-0.72), of which 0.00 comes from values that had to be imputed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 61% of the time over the 31 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 5 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      DRE = Normal (5% of my signal; from dre_suspicious) · PSA = 4.6 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 30.02 mL (4% of my signal; from log_vol, vol) · PSA density = 0.153 (0% of my signal; from psad_calc) · comorbidity = 1 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, csPCa probability
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 61% of the time over the 31 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.57  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.53  ('discuss' tier, fusion_full; weight 1.5)
  EXPERT-EXPERIENCE  BIOPSY, p(biopsy)=1.00  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.54 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('discuss' tier, fusion_full). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          76                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Normal                       E1:not E3:not cohort:not library:not E2:—            -> noted
  psa          4.6 ng/mL                    E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          30.02 mL                     E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.153                        E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.82                         E1:not E3:— cohort:— library:IMP E2:—                -> not_used
  pirads       5                            E1:not E3:IMP cohort:not library:DEC E2:—            -> important
  comorbidity  1 on the problem list        E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: borderline.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened appear to answer the moderator's questions, as the `previous_notes` were retrieved, which should contain the prior biopsy grade, and the `psa_trend` was retrieved to assess significance.

ALIGNMENT WITH THE PANEL
The panel protocol suggests BIOPSY based on a weighted vote, and the retrieved evidence (significant PSA trend, PI-RADS 5) leans towards biopsy, aligning with the panel's conclusion.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade of the prior biopsy? The `previous_notes` state the grade is not explicitly stated, which is a gap. Q2. Is the PSA trend significant? The `psa_trend` indicates the trend is significant.

WHAT CARRIES WEIGHT, AND WHY
prior biopsy: noted / not_used because the registrar reported the grade was not explicitly stated, which is the key missing piece for the guideline context. PSA: important / noted because the PSA trend is significant, which supports the need for further action. My confidence in the record as it stands is borderline due to the missing prior biopsy grade.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a biopsy, as the significant PSA trend and high PI-RADS score support this, despite the lack of an explicitly documented prior biopsy grade.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: borderline)

76yo male, PSA 4.6, PI-RADS 5, prior biopsy grade unrecorded. Rising PSA and new PI-RADS 5 lesion suggest sampling to determine management. Lack of prior biopsy grade makes definitive risk stratification impossible. Biopsy recommended to establish baseline for treatment planning.

What carried weight: bx=important, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes, laboratory_results
